Literature DB >> 33374009

Do SGLT2 inhibitors increase the risk of amputation? Make haste slowly.

Charalambos Vlachopoulos1, Dimitrios Terentes-Printzios1, Konstantinos Tsioufis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33374009     DOI： 10.1093/eurheartj/ehaa1022

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

1.  SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesis.

Authors:  Louis Potier; Kamel Mohammedi; Gilberto Velho; Ronan Roussel
Journal:  Cardiovasc Diabetol       Date:  2021-05-13       Impact factor: 9.951

Review 2.  SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Heart Disease: A Literature Review.

Authors:  Abhishek Kansara; Faiza Mubeen; Jawairia Shakil
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-09-06

3.  Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study.

Authors:  Yen-Chieh Lee; Yaa-Hui Dong; Wei-Shun Yang; Li-Chiu Wu; Jou-Wei Lin; Chia-Hsuin Chang
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.